|
OutcomesAI, a Boston, MA-based healthcare company building a new model of scalable nursing, raised $10m in seed financing.
The round was led by Santé Ventures. As part of the financing, Joe Cunningham, M.D., Founding Managing Director of Santé Ventures; Linda Finkel, Senior Advisor, AVIA; Dennis McWilliams, Managing Director at Santé Ventures; and Kevin White, Ph.D., Co-founder of Tempus AI, will join the Board of Directors, alongside Founder and CEO Kuldeep Singh Rajput. The company intends to use the funds to accelerate its commercial rollout, launch dedicated nursing service lines, and scale enterprise partnerships across health systems, virtual care providers, and pharma. OutcomesAI combines AI voice agents with licensed nurses to extend nursing capacity, reduce costs, and give patients access to care. Glia®, its AI engine purpose-built for nursing, combines AI voice agents that manage inbound and outbound patient calls with licensed OutcomesAI nurses delivering services like triage, virtual care, post-acute follow-up, and patient support programs. Voice agents capture symptoms, schedule visits, coordinate follow-ups, and provide education — all in multiple languages — while nurses are supported by AI productivity tools like real-time scribing and protocol guidance. In 2024, the company launched the OutcomesAI Collaboratory, bringing together five health systems and virtual care companies to validate Glia’s safety, accuracy, and clinical performance. Building on these results, OutcomesAI will publish real-world case studies demonstrating measurable ROI — including early findings where Glia reduced nurse workload by hundreds of hours per month while doubling patient-to-nurse ratios. source; FinSMEs Comments are closed.
|
Archives
October 2025
|